A critical advance in cancer research is occurring with the use of nanobodies to reactivate damaged p53. This vital malignant protector protein is frequently disabled in several forms of malignancies, leading https://thebookpage.com/story7447649/mini-antibodies-revive-the-p53-protein-new-new-pathway-for-malignant-therapy